Logo image of CFX.CA

CANFOR PULP PRODUCTS INC (CFX.CA) Stock Fundamental Analysis

TSX:CFX - Toronto Stock Exchange - CA1375842079 - Common Stock - Currency: CAD

0.8  0 (0%)

Fundamental Rating

2

Taking everything into account, CFX scores 2 out of 10 in our fundamental rating. CFX was compared to 12 industry peers in the Paper & Forest Products industry. Both the profitability and financial health of CFX have multiple concerns. CFX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CFX had negative earnings in the past year.
In the past year CFX had a positive cash flow from operations.
CFX had negative earnings in each of the past 5 years.
In the past 5 years CFX always reported a positive cash flow from operatings.
CFX.CA Yearly Net Income VS EBIT VS OCF VS FCFCFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

CFX has a worse Return On Assets (-37.82%) than 91.67% of its industry peers.
CFX has a Return On Equity of -102.65%. This is amonst the worse of the industry: CFX underperforms 91.67% of its industry peers.
Industry RankSector Rank
ROA -37.82%
ROE -102.65%
ROIC N/A
ROA(3y)-9.99%
ROA(5y)-7.14%
ROE(3y)-18.66%
ROE(5y)-13.13%
ROIC(3y)N/A
ROIC(5y)N/A
CFX.CA Yearly ROA, ROE, ROICCFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

1.3 Margins

CFX's Gross Margin of 20.04% is in line compared to the rest of the industry. CFX outperforms 58.33% of its industry peers.
CFX's Gross Margin has declined in the last couple of years.
CFX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.99%
GM growth 5Y-20.63%
CFX.CA Yearly Profit, Operating, Gross MarginsCFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

CFX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CFX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CFX has about the same amount of shares outstanding.
Compared to 1 year ago, CFX has a worse debt to assets ratio.
CFX.CA Yearly Shares OutstandingCFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CFX.CA Yearly Total Debt VS Total AssetsCFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

CFX has an Altman-Z score of 0.70. This is a bad value and indicates that CFX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.70, CFX is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
CFX has a debt to FCF ratio of 5.55. This is a neutral value as CFX would need 5.55 years to pay back of all of its debts.
CFX has a Debt to FCF ratio of 5.55. This is in the better half of the industry: CFX outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that CFX is somewhat dependend on debt financing.
The Debt to Equity ratio of CFX (0.57) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.55
Altman-Z 0.7
ROIC/WACCN/A
WACC9.78%
CFX.CA Yearly LT Debt VS Equity VS FCFCFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.91 indicates that CFX may have some problems paying its short term obligations.
The Current ratio of CFX (0.91) is worse than 83.33% of its industry peers.
A Quick Ratio of 0.35 indicates that CFX may have some problems paying its short term obligations.
CFX has a Quick ratio of 0.35. This is amonst the worse of the industry: CFX underperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.35
CFX.CA Yearly Current Assets VS Current LiabilitesCFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.26% over the past year.
Looking at the last year, CFX shows a very negative growth in Revenue. The Revenue has decreased by -12.67% in the last year.
CFX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.62% yearly.
EPS 1Y (TTM)84.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.55%
Revenue 1Y (TTM)-12.67%
Revenue growth 3Y-4.03%
Revenue growth 5Y-8.62%
Sales Q2Q%2.33%

3.2 Future

Based on estimates for the next years, CFX will show a small growth in Earnings Per Share. The EPS will grow by 7.45% on average per year.
The Revenue is expected to decrease by -5.20% on average over the next years.
EPS Next Y81.57%
EPS Next 2Y37.92%
EPS Next 3Y24.73%
EPS Next 5Y7.45%
Revenue Next Year-6%
Revenue Next 2Y-7.64%
Revenue Next 3Y-5.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CFX.CA Yearly Revenue VS EstimatesCFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CFX.CA Yearly EPS VS EstimatesCFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2

3

4. Valuation

4.1 Price/Earnings Ratio

CFX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CFX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CFX.CA Price Earnings VS Forward Price EarningsCFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CFX indicates a rather cheap valuation: CFX is cheaper than 100.00% of the companies listed in the same industry.
CFX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CFX is cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.88
EV/EBITDA 0.65
CFX.CA Per share dataCFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

CFX's earnings are expected to grow with 24.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.92%
EPS Next 3Y24.73%

0

5. Dividend

5.1 Amount

No dividends for CFX!.
Industry RankSector Rank
Dividend Yield N/A

CANFOR PULP PRODUCTS INC

TSX:CFX (2/7/2025, 7:00:00 PM)

0.8

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)10-25 2024-10-25/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners5.86%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap52.18M
Analysts71.11
Price Target1.48 (85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.24%
Min EPS beat(2)17.49%
Max EPS beat(2)67%
EPS beat(4)4
Avg EPS beat(4)52.04%
Min EPS beat(4)17.49%
Max EPS beat(4)72.69%
EPS beat(8)4
Avg EPS beat(8)-116.71%
EPS beat(12)6
Avg EPS beat(12)-112.77%
EPS beat(16)9
Avg EPS beat(16)-77.04%
Revenue beat(2)2
Avg Revenue beat(2)1.14%
Min Revenue beat(2)0.47%
Max Revenue beat(2)1.82%
Revenue beat(4)3
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-4.37%
Max Revenue beat(4)1.82%
Revenue beat(8)4
Avg Revenue beat(8)-0.18%
Revenue beat(12)8
Avg Revenue beat(12)1.29%
Revenue beat(16)9
Avg Revenue beat(16)0.62%
PT rev (1m)-3.33%
PT rev (3m)-3.33%
EPS NQ rev (1m)8.82%
EPS NQ rev (3m)27.91%
EPS NY rev (1m)7.69%
EPS NY rev (3m)7.69%
Revenue NQ rev (1m)3.67%
Revenue NQ rev (3m)-14.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF 2.88
P/OCF 0.62
P/B 0.3
P/tB 0.3
EV/EBITDA 0.65
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)0.28
FCFY34.69%
OCF(TTM)1.3
OCFY162.31%
SpS12.72
BVpS2.66
TBVpS2.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.82%
ROE -102.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.04%
FCFM 2.18%
ROA(3y)-9.99%
ROA(5y)-7.14%
ROE(3y)-18.66%
ROE(5y)-13.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.99%
GM growth 5Y-20.63%
F-Score5
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.55
Debt/EBITDA 2.62
Cap/Depr 99.7%
Cap/Sales 8.03%
Interest Coverage N/A
Cash Conversion 222.9%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.35
Altman-Z 0.7
F-Score5
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)92.15%
Cap/Depr(5y)95.3%
Cap/Sales(3y)8.05%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.55%
EPS Next Y81.57%
EPS Next 2Y37.92%
EPS Next 3Y24.73%
EPS Next 5Y7.45%
Revenue 1Y (TTM)-12.67%
Revenue growth 3Y-4.03%
Revenue growth 5Y-8.62%
Sales Q2Q%2.33%
Revenue Next Year-6%
Revenue Next 2Y-7.64%
Revenue Next 3Y-5.2%
Revenue Next 5YN/A
EBIT growth 1Y79.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year129.54%
EBIT Next 3Y33.6%
EBIT Next 5Y20.88%
FCF growth 1Y130.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.1%
OCF growth 3Y-27.69%
OCF growth 5Y-29.95%